Method and composition for treating macular degeneration

Details Method and composition for treating macular degeneration Method and composition for treating macular degeneration

A - Human Necessities

61

K

A61K 31/557 (2006.01) A61P 27/02 (2006.01)

Patent

CA 2757762

Disclosed is a composition for treating macular degeneration in a mammalian subject, which comprises an effective amount of a 15-keto-prostaglandin compound such as 13,14-dihydro-15-keto- 20- ethyl-prostaglandin F2.alpha. isopropyl ester.

La composition ci-décrite permet de traiter la dégénérescence maculaire chez un sujet mammifère, et comprend une quantité efficace d'un composé de 15-céto-prostaglandine tel qu'un ester isopropylique de 13,14-dihydro- 15-céto-20-éthyl-prostaglandine F2a.

Affiliated with

Also associated with

Rating

Method and composition for treating macular degeneration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and composition for treating macular degeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for treating macular degeneration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1954171